Consultation is now open for applications that are anticipated to be considered by the Medical Services Advisory Committee (MSAC) on 30 - 31 March 2023.
MSAC values consultation input from individuals and organisations with an interest in an application that it is considering, including experience of the medical conditions, services or technologies being addressed by the application.
It is anticipated that the below-mentioned applications will proceed to MSAC in March 2023. Consultation input must be received by no later than Friday, 10 February 2023 for it to be considered by MSAC. A consultation survey form is available on the relevant application webpage.
Further information on MSAC’s consultation process is also available on the MSAC website.
Applications scheduled to be considered:
Resubmissions:
1525.1 - Low dose rate brachytherapy for intermediate and high-risk prostate cancer
New applications:
1701 - Deep brain stimulation of the thalamus for the treatment of severe refractory epilepsy
1702 - Abdominal MRI for rare genetic conditions associated with increased risk of renal tumours
1703 - Detection of measurable residual disease in patients with acute lymphoblastic leukaemia
1711 – Review of MBS items for subacromial decompression
1722 - Axicabtagene ciloleucel (Yescarta®) for relapsed or refractory large B-cell lymphoma
1724 – Cardiac technical support services provided by industry employed allied health professionals
To provide input on any of the applications listed, please click on the relevant application link above this box. This will take you to the relevant MSAC webpage where you will be able to download and complete a consultation survey.
Alternatively, you can provide a separate file with your input to commentsMSAC@health.gov.au
Guidance on what sort of information to include in your consultation input can be found on the MSAC website.
Consumers and consumer groups and organisations are welcome to contact the Consumer Evidence and Engagement Unit for questions on current consultations htaconsumerengagement@health.gov.au
Share
Share on Twitter Share on Facebook